Palvella Therapeutics, Inc. (PVLA) — Dilution Risk Analysis

Current Snapshot

Palvella Therapeutics, Inc. (PVLA) has a DilutionWatch score of 41/10 and is classified as MEDIUM risk. The score date in the source data is 2026-10-03T03:45:52.527348.

This page is assembled from sourced share-structure, market-data, SEC-filing, and DilutionWatch fields. Missing values are left blank rather than estimated.

Share Structure

Shares Outstanding
14,408,407 Source
Public Float
9,578,438 Source
Float as % of Outstanding
66.5%

Dilution Risk Score

Score: 41/10 Source (as of 2026-10-03T03:45:52.527348)

Recent SEC Filings

2 shelf registration or ATM offering filings detected in recent history.

Recent filing forms in the source payload: 4 5, 3 1, 8-K 2, 424B5 2.

FormFiledAccession
4 2026-04-17 0001104659-26-044895
3 2026-04-15 0001104659-26-043788
4 2026-04-15 0001104659-26-043793
8-K 2026-04-13 0001193125-26-151979
4 2026-04-01 0001104659-26-038496
4 2026-03-02 0001104659-26-021921
4 2026-03-02 0001104659-26-021922
424B5 2026-02-26 0001104659-26-020659
8-K 2026-02-26 0001104659-26-020667
424B5 2026-02-24 0001104659-26-019152

Dilution Risk Drivers

DriverStored ValueSource
ATM offering capacity remaining $200,000,000 Source
Cash runway 84 months Source
Three-year share count growth 1357.57% Source

DilutionWatch Analysis

Risk Level
MEDIUM (Score: 41/10) Source
Cash Runway
84 months Source
ATM Offering Capacity Remaining
$200,000,000 Source
Share Count Growth (3-Year)
1357.57% Source

What This Page Does Not Estimate

DilutionWatch does not infer missing cash runway, authorized share count, ATM capacity, shelf capacity, or share-growth values on this page. A blank field means the current source payload did not provide a usable value with provenance.

Scores and classifications are shown only when supplied by the DilutionWatch data layer. SEC filing rows link to their source accession when a filing URL is available.